Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A.

Clin Ther. 2001 Jul;23(7):1040-58.

PMID:
11519769
2.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
3.
4.
5.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
6.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
7.

The effects of antidepressants on sexual functioning in depressed patients: a review.

Ferguson JM.

J Clin Psychiatry. 2001;62 Suppl 3:22-34. Review.

8.

Bupropion sustained release: side effect profile.

Settle EC Jr.

J Clin Psychiatry. 1998;59 Suppl 4:32-6. Review.

9.

Bupropion sustained release: a therapeutic overview.

Davidson JR, Connor KM.

J Clin Psychiatry. 1998;59 Suppl 4:25-31. Review.

10.

The efficacy and tolerability of bupropion in the treatment of major depressive disorder.

Moreira R.

Clin Drug Investig. 2011 Oct 19;31 Suppl 1:5-17. doi: 10.2165/1159616-S0-000000000-00000. Review.

PMID:
22015858
11.

Care of the sexually active depressed patient.

Hirschfeld RM.

J Clin Psychiatry. 1999;60 Suppl 17:32-5; discussion 46-8. Review.

12.

Reboxetine: a review of antidepressant tolerability.

Mucci M.

J Psychopharmacol. 1997;11(4 Suppl):S33-7. Review.

PMID:
9438231
13.

Reboxetine: additional benefits to the depressed patient.

Montgomery SA.

J Psychopharmacol. 1997;11(4 Suppl):S9-15. Review.

PMID:
9438228
14.

[Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI].

Montejo AL, Llorca G, Izquierdo JA, Carrasco JL, Daniel E, Pérez-Sola V, Vicens E, Bousoño M, Sánchez-Iglesias S, Franco M, Cabezudo A, Rubio V, Ortega MA, Puigdellivol M, Domenech JR, Allué B, Sáez C, Mezquita B, Gálvez I, Pacheco L, de Miguel E.

Actas Esp Psiquiatr. 1999 Jan-Feb;27(1):23-34. Review. Spanish.

PMID:
10380144
15.
16.

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.

Nieuwstraten CE, Dolovich LR.

Ann Pharmacother. 2001 Dec;35(12):1608-13. Review.

PMID:
11793630
17.

Fluoxetine: activating and sedating effects.

Beasley CM Jr, Potvin JH.

Int Clin Psychopharmacol. 1993 Winter;8(4):271-5. Review.

PMID:
8277147
18.

Sexual side effects of antidepressants.

Rothschild AJ.

J Clin Psychiatry. 2000;61 Suppl 11:28-36. Review.

19.

New directions in the treatment of antidepressant-induced sexual dysfunction.

Rothschild AJ.

Clin Ther. 2000;22 Suppl A:A42-57; discussion A58-61. Review.

PMID:
10815649
20.

Strategies for the treatment of antidepressant-related sexual dysfunction.

Zajecka J.

J Clin Psychiatry. 2001;62 Suppl 3:35-43. Review.

Supplemental Content

Support Center